The quality of guidelines in non-pharmacological prevention and management of chemotherapy-induced neuropathy: A review

Chemotherapy-induced peripheral neuropathy is a common adverse effect occurring in patients undergoing neurotoxic chemotherapy. However, there is no FDA-approved treatment option for it. Given the importance of clinical practice guidelines in this area, this study aimed to determine the methodologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Salarvand, Shahin, Hemati, Simin, Adibi, Payman, Taleghani, Fariba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207849/
https://www.ncbi.nlm.nih.gov/pubmed/30464808
http://dx.doi.org/10.4081/oncol.2018.359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207849/
https://www.ncbi.nlm.nih.gov/pubmed/30464808
http://dx.doi.org/10.4081/oncol.2018.359

Ejemplares similares